Ovarian ascites-derived Hospicells promote angiogenesis via activation of macrophages

被引:35
作者
Castells, Magali [1 ,2 ]
Thibault, Benoit [1 ,2 ]
Mery, Eliane [1 ]
Golzio, Muriel [2 ,3 ]
Pasquet, Marlene [1 ]
Hennebelle, Isabelle [1 ]
Bourin, Philippe [4 ]
Mirshahi, Massoud [5 ]
Delord, Jean Pierre [1 ]
Querleu, Denis [1 ]
Couderc, Bettina [1 ,2 ]
机构
[1] Inst Claudius Regaud, EA4553, F-31062 Toulouse, France
[2] Univ Toulouse 3, F-31052 Toulouse, France
[3] Ctr Natl Rech Sci, Inst Pharmacol & Biol Struct, F-31077 Toulouse, France
[4] Etab Francais Sang Pyrenees Mediterranee, Serv Ingn Cellulaire, F-31300 Toulouse, France
[5] INSERM, UMR 736, F-75000 Paris, France
关键词
Ovarian cancer; CA-MSC; Cytokines; Angiogenesis; Macrophages; MESENCHYMAL STEM-CELLS; CANCER CELLS; ONCOLOGIC TROGOCYTOSIS; TUMOR PROGRESSION; EXPRESSION; CARCINOMA; DIFFERENTIATION; STROMA; FIBROBLASTS; CONTRIBUTES;
D O I
10.1016/j.canlet.2012.07.020
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Within the microenvironment, Carcinoma-associated mesenchymal stem cells (Hospicells) are able to influence ovarian tumor development via, among others, the facilitation of angiogenesis in the tumor site allowing an accelerated tumor growth. We demonstrate the presence of a chemotactism between endothelial cells and Hospicells, and a cell line specific increased secretion of pro-angiogenic cytokines such as IL-6, IL-8 and VEGF from ovarian adenocarcinoma cells. Hospicells are also able to attract and activate macrophages to a M2 phenotype and allow them to secrete a huge quantity of pro-angiogenic cytokines, favorable to tumor progression of all the associated ovarian adenocarcinoma cells tested. (C) 2012 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:59 / 68
页数:10
相关论文
共 46 条
[1]   Molecular regulation of angiogenesis and lymphangiogenesis [J].
Adams, Ralf H. ;
Alitalo, Kari .
NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2007, 8 (06) :464-478
[2]   The biology of ovarian cancer: new opportunities for translation [J].
Bast, Robert C., Jr. ;
Hennessy, Bryan ;
Mills, Gordon B. .
NATURE REVIEWS CANCER, 2009, 9 (06) :415-428
[3]   VEGF expression by mesenchymal stem cells contributes to angiogenesis in pancreatic carcinoma [J].
Beckermann, B. M. ;
Kallifatidis, G. ;
Groth, A. ;
Frommhold, D. ;
Apel, A. ;
Mattern, J. ;
Salnikov, A. V. ;
Moldenhauer, G. ;
Wagner, W. ;
Diehlmann, A. ;
Saffrich, R. ;
Schubert, M. ;
Ho, A. D. ;
Giese, N. ;
Buechler, M. W. ;
Friess, H. ;
Buechler, P. ;
Herr, I. .
BRITISH JOURNAL OF CANCER, 2008, 99 (04) :622-631
[4]  
BENARD J, 1985, CANCER RES, V45, P4970
[5]   Rapid Biocompatibility Analysis of Materials via In Vivo Fluorescence Imaging of Mouse Models [J].
Bratlie, Kaitlin M. ;
Dang, Tram T. ;
Lyle, Stephen ;
Nahrendorf, Matthias ;
Weissleder, Ralph ;
Langer, Robert ;
Anderson, Daniel G. .
PLOS ONE, 2010, 5 (03)
[6]   Macrophages programmed by apoptotic cells promote angiogenesis via prostaglandin E2 [J].
Brecht, Kerstin ;
Weigert, Andreas ;
Hu, Jiong ;
Popp, Ruediger ;
Fisslthaler, Beate ;
Korff, Thomas ;
Fleming, Ingrid ;
Geisslinger, Gerd ;
Bruene, Bernhard .
FASEB JOURNAL, 2011, 25 (07) :2408-2417
[7]   Cancer of the ovary [J].
Cannistra, SA .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (24) :2519-2529
[8]   Angiogenesis in cancer and other diseases [J].
Carmeliet, P ;
Jain, RK .
NATURE, 2000, 407 (6801) :249-257
[9]   The tumor-promoting actions of TNF-α involve TNFR1 and IL-17 in ovarian cancer in mice and humans [J].
Charles, Kellie A. ;
Kulbe, Hagen ;
Soper, Robin ;
Escorcio-Correia, Monica ;
Lawrence, Toby ;
Schultheis, Anne ;
Chakravarty, Probir ;
Thompson, Richard G. ;
Kollias, George ;
Smyth, John F. ;
Balkwill, Frances R. ;
Hagemann, Thorsten .
JOURNAL OF CLINICAL INVESTIGATION, 2009, 119 (10) :3011-3023
[10]   Human umbilical cord mesenchymal stem cells hUC-MSCs exert immunosuppressive activities through a PGE2-dependent mechanism [J].
Chen, Ke ;
Wang, Ding ;
Du, Wei Ting ;
Han, Zhi-Bo ;
Ren, He ;
Chi, Ying ;
Yang, Shao Guang ;
Zhu, Delin ;
Bayard, Francis ;
Han, Zhong Chao .
CLINICAL IMMUNOLOGY, 2010, 135 (03) :448-458